Pelvic Radiotherapy and Sexual Function in Men and Women

Journal of Sexual Medicine

Volumn 10, Issue SUPPL., 2013, Pages 53-64

  Incrocci, Luca ^a   Jensen, Pernille Tine ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bladder cancer; Cervical cancer; Colorectal cancer; Erectile dysfunction; Gynecological cancer; Pelvic radiotherapy; Penile cancer; Prostate cancer; Sexual dysfunction; Testicular cancer

Indexed keywords

BIOLOGICAL FACTOR; PHOSPHODIESTERASE V INHIBITOR; PROSTATE SPECIFIC ANTIGEN; SILDENAFIL;

ABDOMINAL RADIOTHERAPY; ANUS CANCER; BLADDER CANCER; BLADDER CAPACITY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COLORECTAL CANCER; CYSTECTOMY; DRUG EFFICACY; ENDOMETRIUM CANCER; ENDOTHELIUM LESION; ERECTILE DYSFUNCTION; FEMALE SEXUAL DYSFUNCTION; HEMATURIA; HORMONE SUBSTITUTION; HUMAN; IMPOTENCE; INTENSITY MODULATED RADIATION THERAPY; INTESTINE STENOSIS; LEG EDEMA; LIBIDO DISORDER; LYMPHEDEMA; MALE SEXUAL DYSFUNCTION; ORCHIECTOMY; OVARY INSUFFICIENCY; PELVIS CANCER; PELVIS LYMPHADENECTOMY; PELVIS RADIOTHERAPY; PENIS CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOEDUCATION; PSYCHOLOGICAL ASPECT; RADIATION DOSE; RADIATION INJURY; RADICAL HYSTERECTOMY; REVIEW; SEXUAL FUNCTION; SEXUAL SATISFACTION; SEXUALITY; SOCIAL ASPECT; TESTIS CANCER; URETER OBSTRUCTION; UTERINE CERVIX CANCER; VAGINA ATROPHY; VAGINAL DRYNESS; VULVA CANCER;

EID: 84873415511     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12010     Document Type: Article

References (153)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Addis ME, Mahalik JR. Men, masculinity, and the contexts of help seeking. Am Psychol 2003;58:5-14.
3. Ekwall E, Ternestedt BM, Sorbe B. Important aspects of health care for women with gynecologic cancer. Oncol Nurs Forum 2003;30:313-9.
4. Hendren SK, O'Connor BI, Liu M, Asano T, Cohen Z, Swallow CJ, Macrae HM, Gryfe R, McLeod RS. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005;242:212-23.
5. Juraskova I, Butow P, Robertson R, Sharpe L, McLeod C, Hacker N. Post-treatment sexual adjustment following cervical and endometrial cancer: A qualitative insight. Psychooncology 2003;12:279.
6. Stead ML. Sexual dysfunction after treatment for gynaecologic and breast malignancies. Curr Opin Obstet Gynecol 2003;15:57-61.
7. Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: A new understanding to improve management of symptomatic patients. Lancet Oncol 2007;8:1007-17.
8. Bye A, Trope C, Loge JH, Hjermstad M, Kaasa S. Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy-Evaluation of long-term effects of diagnosis and treatment. Acta Oncol 2000;39:173-80.
9. Grigsby PW, Russell A, Bruner D, Eifel P, Koh WJ, Spanos W, Stetz J, Stitt JA, Sullivan J. Late injury of cancer therapy on the female reproductive tract. Int J Radiat Oncol Biol Phys 1995;31:1281-99.
10. Majewski W, Tarnawski R. Acute and late toxicity in radical radiotherapy for bladder cancer. Clin Oncol (R Coll Radiol) 2009;21:598-609.
11. Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 1995;31:1257-80.
12. Incrocci L, Slob AK. Incidence, etiology, and therapy for erectile dysfunction after external beam radiotherapy for prostate cancer. Urology 2002;60:1-7.
13. Incrocci L, Slob AK, Levendag PC. Sexual (dys)function after radiotherapy for prostate cancer: A review. Int J Radiat Oncol Biol Phys 2002;52:681-93.
14. Incrocci L. Sexual function after external-beam radiotherapy for prostate cancer: What do we know? Crit Rev Oncol Hematol 2006;57:165-73.
15. Zelefsky MJ, Eid JF. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys 1998;40:129-33.
16. DiBiase SJ, Wallner K, Tralins K, Sutlief S. Brachytherapy radiation doses to the neurovascular bundles. Int J Radiat Oncol Biol Phys 2000;46:1301-7.
17. Merrick GS, Butler WM, Dorsey AT, Lief JH, Donzella JG. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 2000;48:1069-74.
18. Merrick GS, Butler WM, Wallner KE, Lief JH, Anderson RL, Smeiles BJ, Galbreath RW, Benson ML. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys 2002;54:1055-62.
19. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Kurko BS, Lief JH, Allen ZA. Erectile function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005;62:437-47.
20. Fisch BM, Pickett B, Weinberg V, Roach M. Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology 2001;57:955-9.
21. Kiteley RA, Lee WR, deGuzman AF, Mirzaei M, McCullough DL. Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy. Brachytherapy 2002;1:90-4.
22. Selek U, Cheung R, Lii M, Allen P, Steadham RE, Vantreese TR Jr, Little DJ, Rosen II, Kuban D. Erectile dysfunction and radiation dose to penile base structures: A lack of correlation. Int J Radiat Oncol Biol Phys 2004;59:1039-46.
23. Roach M, Winter K, Michalski JM, Cox JD, Purdy JA, Bosch W, Lin X, Shipley WS. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys 2004;60:1351-6.
24. Wernicke AG, Valicenti R, Dieva K, Houser C, Pequignot E. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004;60:1357-63.
25. Wright JL, Newhouse JH, Laguna JL, Vecchio D, Ennis RD. Localization of neurovascular bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in erectile dysfunction after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2004;59:426-35.
26. Macdonald AG, Keyes M, Kruk A, Duncan G, Moravan V, Morris WJ. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: Is dose to the penile bulb important? Int J Radiat Oncol Biol Phys 2005;63:155-63.
27. Mangar SA, Sydes MR, Tucker HL, Coffey J, Sohaib SA, Gianolini S, Webb S, Khoo VS, Dearnaley DP. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: Using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397). Radiother Oncol 2006;80:355-62.
28. Brown MW, Brooks JP, Albert PS, Poggi MM. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma. Prostate Cancer Prostatic Dis 2007;10:189-93.
29. van der Wielen GJ, Hoogeman MS, Dohle GR, van Putten WL, Incrocci L. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: Results from a dose-escalation trial. Int J Radiat Oncol Biol Phys 2008;71:795-800.
30. Solan AN, Cesaretti JA, Stone NN, Stock RG. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy. Int J Radiat Oncol Biol Phys 2009;73:1468-74.
31. van der Wielen GJ, Mulhall JP, Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: A critical review. Radiother Oncol 2007;84:107-13.
32. Arai Y, Aoki Y, Okubo K, Maeda H, Terada N, Matsuta Y, Maekawa S, Ogura K. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: A prospective study. J Urol 2000;164:1206-11.
33. Stock RG, Kao J, Stone NN. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 2001;165:436-9.
34. Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW. Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2001;50:1235-42.
35. Allal AS, Sprangers MA, Laurencet F, Reymond MA, Kurtz JM. Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 1999;80:1588-94.
36. Anacak Y, Yalman D, Ozsaran Z, Haydaroglu A. Late radiation effects to the rectum and bladder in gynecologic cancer patients: The comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems. Int J Radiat Oncol Biol Phys 2001;50:1107-12.
37. Andersen BL, Elliot ML. Sexuality for women with cancer: Assessment, theory, and treatment. Sex Disabil 1993;11:8-37.
38. Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med 1999;340:1383-9.
39. Bye A, Ose T, Kaasa S. Quality of life during pelvic radiotherapy. Acta Obstet Gynecol Scand 1995;74:147-52.
40. Cull A, Cowie VJ, Farquharson DI, Livingstone JR, Smart GE, Elton RA. Early stage cervical cancer: Psychosocial and sexual outcomes of treatment. Br J Cancer 1993;68:1216-20.
41. Schover LR, Evans RB, von Eschenbach AC. Sexual rehabilitation in a cancer center: Diagnosis and outcome in 384 consultations. Arch Sex Behav 1987;16:445-61.
42. Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand 2002;81:443-50.
43. Flay LD, Matthews JH. The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys 1995;31:399-404.
44. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 2005;23:7428-36.
45. Greimel ER, Winter R, Kapp KS, Haas J. Quality of life and sexual functioning after cervical cancer treatment: A long-term follow-up study. Psychooncology 2009;18:476-82.
46. Jensen P, Groenvold M, Klee M, Thranov I, Petersen M, Machin D. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2003;56:937-49.
47. Schover LR, Fife M, Gershenson DM. Sexual dysfunction and treatment for early stage cervical cancer. Cancer 1989;63:204-12.
48. Abitbol MM, Davenport JH. The irradiated vagina. Obstet Gynecol 1974;44:249-56.
49. Denton AS, Maher EJ. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database Syst Rev 2003;(1):CD003750.
50. Fokdal L, Hoyer M, Meldgaard P, von der Maase H. Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol 2004;72:139-45.
51. Jensen PT, Roed H, Engelholm SA, Rosendal F. Pulsed dose rate (PDR) brachytherapy as salvage treatment of locally advanced or recurrent gynecologic cancer. Int J Radiat Oncol Biol Phys 1998;42:1041-7.
52. Rubin P, Casarett GW. The female genital tract. In: Rubin P, Casarett GW, eds. Clinical radiation pathology. Philadelphia: W.B. Saunders; 1986:396-422.
53. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003;88:5307-14.
54. Pilepich MV, Krall JM, Al-Sarraf M, John MJ, Doggett RL, Sause WT, Lawton CA, Abrams RA, Rotman M, Rubin P. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the Radiation Therapy Oncology Group. Urology 1995;45:616-23.
55. Beckendorf V, Hay M, Rozan R, Lagrange JL, N'Guyen T, Giraud B. Changes in sexual function after radiotherapy treatment of prostate cancer. Br J Urol 1996;77:118-23.
56. Beard CJ, Propert KJ, Rieker PP, Clark JA, Kaplan I, Kantoff PW, Talcott JA. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multiinstitutional outcomes study. J Clin Oncol 1997;15:223-9.
57. Borghede G, Hedelin H. Radiotherapy of localised prostate cancer. Analysis of late treatment complications. A prospective study. Radiother Oncol 1997;43:139-46.
58. Turner SL, Adams K, Bull CA, Berry MP. Sexual dysfunction after radical radiation therapy for prostate cancer: A prospective evaluation. Urology 1999;54:124-9.
59. van der Wielen GJ, van Putten WL, Incrocci L. Sexual function after three-dimensional conformal radiotherapy for prostate cancer: Results from a dose-escalation trial. Int J Radiat Oncol Biol Phys 2007;68:479-84.
60. Pinkawa M, Gagel B, Piroth MD, Fischedick K, Asadpour B, Kehl M, Klotz J, Eble MJ. Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur Urol 2009;55:227-34.
61. Arterbery VE, Frazier A, Dalmia P, Siefer J, Lutz M, Porter A. Quality of life after permanent prostate implant. Semin Surg Oncol 1997;13:461-4.
62. Joly F, Brune D, Couette JE, Lesaunier F, Heron JF, Peny J, Henry-Amar M. Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer. Ann Oncol 1998;9:751-7.
63. Kestin LL, Martinez AA, Stromberg JS, Edmundson GK, Gustafson GS, Brabbins DS, Chen PY, Vicini FA. Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. J Clin Oncol 2000;18:2869-80.
64. Koutrouvelis PG. Three-dimensional stereotactic posterior ischiorectal space computerized tomography guided brachytherapy of prostate cancer: A preliminary report. J Urol 1998;159:142-5.
65. Martinez A, Gonzalez J, Stromberg J, Edmundson G, Plunkett M, Gustafson G, Brown D, Yan D, Vicini F, Brabbins D. Conformal prostate brachytherapy: Initial experience of a phase I/II dose-escalating trial. Int J Radiat Oncol Biol Phys 1995;33:1019-27.
66. Sanchez-Ortiz RF, Broderick GA, Rovner ES, Wein AJ, Whittington R, Malkowicz SB. Erectile function and quality of life after interstitial radiation therapy for prostate cancer. Int J Impot Res 2000;12(suppl 3):S18-24.
67. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358:1250-61.
68. Sharkey J, Chovnick SD, Behar RJ, Perez R, Otheguy J, Solc Z, Huff W, Cantor A. Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: A preliminary report of 434 patients. Urology 1998;51:796-803.
69. Sharkey J, Chovnick SD, Behar RJ, Perez R, Otheguy J, Rabinowitz R, Steele J, Webster C, Donohue M, Solc Z, Huff W, Cantor A. Minimally invasive treatment for localized adenocarcinoma of the prostate: Review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy. J Endourol 2000;14:343-50.
70. Zelefsky MJ, Hollister T, Raben A, Matthews S, Wallner KE. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2000;47:1261-6.
71. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet 2009;374:239-49.
72. Merseburger AS, Matuschek I, Kuczyk MA. Bladder preserving strategies for muscle-invasive bladder cancer. Curr Opin Urol 2008;18:513-8.
73. Little FA, Howard GC. Sexual function following radical radiotherapy for bladder cancer. Radiother Oncol 1998;49:157-61.
74. Henningsohn L, Wijkstrom H, Steven K, Pedersen J, Ahlstrand C, Aus G, Kallestrup EB, Bergmark K, Onelov E, Steineck G. Relative importance of sources of symptom-induced distress in urinary bladder cancer survivors. Eur Urol 2003;43:651-62.
75. Henningsohn L, Wijkstrom H, Dickman PW, Bergmark K, Steineck G. Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother Oncol 2002;62:215-25.
76. Misra S, Chaturvedi A, Misra NC. Penile carcinoma: A challenge for the developing world. Lancet Oncol 2004;5:240-7.
77. Windahl T, Skeppner E, Andersson SO, Fugl-Meyer KS. Sexual function and satisfaction in men after laser treatment for penile carcinoma. J Urol 2004;172:648-51.
78. Opjordsmoen S, Waehre H, Aass N, Fossa SD. Sexuality in patients treated for penile cancer: Patients' experience and doctors' judgement. Br J Urol 1994;73:554-60.
79. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: A review. J Urol 2003;170:5-11.
80. van Basten JP, Schrafford KH, Sleijfer DT, Pras E, van Driel MF, Hoekstra HJ. Current concepts about testicular cancer. Eur J Surg Oncol 1997;23:354-60.
81. Jonker-Pool G, van Basten JP, Hoekstra HJ, van Driel MF, Sleijfer DT, Koops HS, van de Wiel HB. Sexual functioning after treatment for testicular cancer: Comparison of treatment modalities. Cancer 1997;80:454-64.
82. Tinkler SD, Howard GC, Kerr GR. Sexual morbidity following radiotherapy for germ cell tumours of the testis. Radiother Oncol 1992;25:207-12.
83. Caffo O, Amichetti M. Evaluation of sexual life after orchidectomy followed by radiotherapy for early-stage seminoma of the testis. BJU Int 1999;83:462-8.
84. Incrocci L, Hop WC, Wijnmaalen A, Slob AK. Treatment outcome, body image, and sexual functioning after orchiectomy and radiotherapy for Stage I-II testicular seminoma. Int J Radiat Oncol Biol Phys 2002;53:1165-73.
85. Arai Y, Kawakita M, Okada Y, Yoshida O. Sexuality and fertility in long-term survivors of testicular cancer. J Clin Oncol 1997;15:1444-8.
86. Nazareth I, Lewin J, King M. Sexual dysfunction after treatment for testicular cancer: A systematic review. J Psychosom Res 2001;51:735-43.
87. Gritz ER, Wellisch DK, Wang HJ, Siau J, Landsverk JA, Cosgrove MD. Long-term effects of testicular cancer on sexual functioning in married couples. Cancer 1989;64:1560-7.
88. Incrocci L, Bosch JL, Slob AK. Testicular prostheses: Body image and sexual functioning. BJU Int 1999;84:1043-5.
89. Adshead J, Khoubehi B, Wood J, Rustin G. Testicular implants and patient satisfaction: A questionnaire-based study of men after orchidectomy for testicular cancer. BJU Int 2001;88:559-62.
90. Lynch MJ, Pryor JP. Testicular prostheses: The patient's perception. Br J Urol 1992;70:420-2.
91. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 2005;23:8697-705.
92. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Late adverse effects of radiation therapy for rectal cancer-A systematic overview. Acta Oncol 2007;46:504-16.
93. Bonnel C, Parc YR, Pocard M, Dehni N, Caplin S, Parc R, Tiret E. Effects of preoperative radiotherapy for primary resectable rectal adenocarcinoma on male sexual and urinary function. Dis Colon Rectum 2002;45:934-9.
94. Lange MM, Marijnen CA, Maas CP, Putter H, Rutten HJ, Stiggelbout AM, Meershoek-Klein KE, van de Velde CJ. Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 2009;45:1578-88.
95. Marijnen CA, van de Velde CJ, Putter H, van den Brink M, Maas CP, Martijn H, Rutten HJ, Wiggers T, Kranenbarg EK, Leer JW, Stiggelbout AM. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of a multicenter randomized trial. J Clin Oncol 2005;23:1847-58.
96. Wong RK, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007;(2):CD002102.
97. Maas CP, Moriya Y, Steup WH, Kiebert GM, Kranenbarg WM, van de Velde CJ. Radical and nerve-preserving surgery for rectal cancer in The Netherlands: A prospective study on morbidity and functional outcome. Br J Surg 1998;85:92-7.
98. Lange MM, van de Velde CJ. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol 2011;8:51-7.
99. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000;342:792-800.
100. Young SC, Solomon MJ, Hruby G, Frizelle FA. Review of 120 anal cancer patients. Colorectal Dis 2009;11:909-14.
101. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040-9.
102. Jephcott CR, Paltiel C, Hay J. Quality of life after non-surgical treatment of anal carcinoma: A case control study of long-term survivors. Clin Oncol (R Coll Radiol) 2004;16:530-5.
103. Bergmark K, Lundqvist EA, Steineck G. Swedish study of women treated for cervical cancer; Gynecologic cancer often affects sexuality. Lakartidningen 2000;97:5347-55.
104. Dunberger G, Lind H, Steineck G, Waldenstrom AC, Nyberg T, Al-Abany M, Nyberg U, Avall-Lundqvist E. Fecal incontinence affecting quality of life and social functioning among long-term gynecological cancer survivors. Int J Gynecol Cancer 2010;20:449-60.
105. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, Steen-Banasik E, Beerman H, van Lent M. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000;355:1404-11.
106. Nout RA, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Stenfert Kroese MC, van Bunningen BN, Smit VT, Nijman HW, van den Tol PP, Creutzberg CL. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: First results of the randomized PORTEC-2 trial. J Clin Oncol 2009;27:3547-56.
107. Bradley S, Rose S, Lutgendorf S, Costanzo E, Anderson B. Quality of life and mental health in cervical and endometrial cancer survivors. Gynecol Oncol 2006;100:479-86.
108. Jereczek-Fossa BA, Jassem J, Badzio A. Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer. Int J Radiat Oncol Biol Phys 2002;52:476-82.
109. Klee M, Machin D. Health-related quality of life of patients with endometrial cancer who are disease-free following external irradiation. Acta Oncol 2001;40:816-24.
110. Lalos O, Lalos A. Urinary, climacteric and sexual symptoms one year after treatment of endometrial and cervical cancer. Eur J Gynaecol Oncol 1996;17:128-36.
111. Nunns D, Williamson K, Swaney L, Davy M. The morbidity of surgery and adjuvant radiotherapy in the management of endometrial carcinoma. Int J Gynecol Cancer 2000;10:233-8.
112. van de Poll-Franse LV, Mols F, Essink-Bot ML, Haartsen JE, Vingerhoets AJ, Lybeert ML, van den Berg HA, Coebergh JW. Impact of external beam adjuvant radiotherapy on health-related quality of life for long-term survivors of endometrial adenocarcinoma: A population-based study. Int J Radiat Oncol Biol Phys 2007;69:125-32.
113. Andersen BL, Hacker NF. Psychosexual adjustment after vulvar surgery. Obstet Gynecol 1983;62:457-62.
114. Barton DP. The prevention and management of treatment related morbidity in vulval cancer. Best Pract Res Clin Obstet Gynaecol 2003;17:683-701.
115. Corney RH, Crowther ME, Everett H, Howells A, Shepherd JH. Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. Br J Obstet Gynaecol 1993;100:73-8.
116. Green MS, Naumann RW, Elliot M, Hall JB, Higgins RV, Grigsby JH. Sexual dysfunction following vulvectomy. Gynecol Oncol 2000;77:73-7.
117. Janda M, Obermair A, Cella D, Crandon AJ, Trimmel M. Vulvar cancer patients' quality of life: A qualitative assessment. Int J Gynecol Cancer 2004;14:875-81.
118. Oonk MH, van Os MA, de Bock GH, de Hullu JA, Ansink AC, van der Zee AG. A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol 2009;113:301-5.
119. Weijmar Schultz WC, Wijma K, Van de Wiel HBM, Bouma J, Janssens J. Sexual rehabilitation of radical vulvectomy patients: A pilot study. J Psychosom Obstet Gynaecol 1986;5:119-26.
120. Weijmar Schultz WC, van de Wiel HB, Bouma J, Janssens J, Littlewood J. Psychosexual functioning after the treatment of cancer of the vulva: A longitudinal study. Cancer 1990;66:402-7.
121. Andersen BL, Turnquist D, LaPolla J, Turner D. Sexual functioning after treatment of in situ vulvar cancer: Preliminary report. Obstet Gynecol 1988;71:15-9.
122. Andreasson B, Moth I, Jensen SB, Bock JE. Sexual function and somatopsychic reactions in vulvectomy-operated women and their partners. Acta Obstet Gynecol Scand 1986;65:7-10.
123. Moth I, Andreasson B, Jensen SB, Bock JE. Sexual function and somatopsychic reactions after vulvectomy: A preliminary report. Dan Med Bull 1983;30(suppl 2):27-30.
124. Pierce LJ, Whittington R, Hanno PM, English W, Wein AJ, Goodman RL. Pharmacologic erection with intracavernosal injection for men with sexual dysfunction following irradiation: A preliminary report. Int J Radiat Oncol Biol Phys 1991;21:1311-4.
125. Dubocq FM, Bianco FJ Jr, Maralani SJ, Forman JD, Dhabuwala CB. Outcome analysis of penile implant surgery after external beam radiation for prostate cancer. J Urol 1997;158:1787-90.
126. Zelefsky MJ, McKee AB, Lee H, Leibel SA. Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate. Urology 1999;53:775-8.
127. Kedia S, Zippe CD, Agarwal A, Nelson DR, Lakin MM. Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer. Urology 1999;54:308-12.
128. Valicenti RK, Choi E, Chen C, Lu JD, Hirsch IH, Mulholland GS, Gomella LG. Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy. Urology 2001;57:769-73.
129. Weber DC, Bieri S, Kurtz JM, Miralbell R. Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer. J Clin Oncol 1999;17:3444-9.
130. Ohebshalom M, Parker M, Guhring P, Mulhall JP. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: Temporal considerations. J Urol 2005;174:258-62.
131. Incrocci L, Koper PC, Hop WC, Slob AK. Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: A randomized, double-blind, placebo-controlled, cross-over study. Int J Radiat Oncol Biol Phys 2001;51:1190-5.
132. Incrocci L, Hop WC, Slob AK. Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy for prostate cancer. Urology 2003;62:116-20.
133. Watkins BD, James JL, Bryan CJ, Pisansky TM, Rotman M, Corbett T, Speight J, Byhardt R, Sandler H, Bentzen S, Kachnic L, Berk L. Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: Results of RTOG 0215. J Sex Med 2011;8:1228-38.
134. Incrocci L, Slagter C, Slob AK, Hop WC. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys 2006;66:439-44.
135. Incrocci L, Slob AK, Hop WC. Tadalafil (Cialis) and erectile dysfunction after radiotherapy for prostate cancer: An open-label extension of a blinded trial. Urology 2007;70:1190-3.
136. Berman L, Berman J, Felder S, Pollets D, Chhabra S, Miles M, Powell JA. Seeking help for sexual function complaints: What gynecologists need to know about the female patient's experience. Fertil Steril 2003;79:572-6.
137. Chivers ML, Rosen RC. Phosphodiesterase type 5 inhibitors and female sexual response: Faulty protocols or paradigms? J Sex Med 2010;7:858-72.
138. Kokcu A, Cetinkaya MB, Yanik F, Alper T, Malatyalioglu E. The comparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women. Maturitas 2000;36:75-80.
139. Laan E, van Lunsen RH, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001;4:28-41.
140. Nathorst-Boos J, Wiklund I, Mattsson L, Sandin K, von Schoultz B. Is sexual life influenced by transdermal estrogen therapy? Acta Obstet Gynecol Scand 1993;72:656-60.
141. Nathorst-Boos J, Hammar M. Effect on sexual life-A comparison between tibolone and a continuous estradiol-norethisterone acetate regimen. Maturitas 1997;26:15-20.
142. Ploch E. Hormonal replacement therapy in patients after cervical cancer treatment. Gynecol Oncol 1987;26:169-77.
143. Pitkin RM, VanVoorhis LW. Postirradiation vaginitis. An evaluation of prophylaxis with topical estrogen. Radiology 1971;99:417-21.
144. Pitkin RM, Bradbury JT. The effect of topical estrogen on irradiated vaginal epithelium. Am J Obstet Gynecol 1965;92:175-82.
145. Hintz BL, Kagan AR, Gilbert HA, Rao AR, Chan P, Nussbaum H. Systemic absorption of conjugated estrogenic cream by the irradiated vagina. Gynecol Oncol 1981;12:75-82.
146. Decruze SB, Guthrie D, Magnani R. Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol (R Coll Radiol) 1999;11:46-8.
147. Robinson JW, Faris PD, Scott CB. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 1999;44:497-506.
148. Cullen K, Fergus K, Dasgupta T, Fitch M, Doyle C, Adams L. From "sex toy" to intrusive imposition: A qualitative examination of women's experiences with vaginal dilator use following treatment for gynecological cancer. J Sex Med 2012;9:1162-73.
149. Sethi A, Mohideen N, Leybovich L, Mulhall J. Role of IMRT in reducing penile doses in dose escalation for prostate cancer. Int J Radiat Oncol Biol Phys 2003;55:970-8.
150. Mulhall JP, Morgentaler A. Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med 2007;4:538-43.
151. Schiff JD, Bar-Chama N, Cesaretti J, Stock R. Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function. BJU Int 2006;98:1255-8.
152. Incrocci L. Talking about sex to oncologists and cancer to sexologists. J Sex Med 2011;8:3251-3.
153. Stead ML, Fallowfield L, Brown JM, Selby P. Communication about sexual problems and sexual concerns in ovarian cancer: Qualitative study. BMJ 2001;323:836-7.